Andrew Glashow, Chairman and CEO of CLS Holdings, was a panelist on “The ROI of Manufactured Cannabis Products vs Plain Old Flower” at Benzinga’s Cannabis Capital Conference. Glashow shared that when the founders of his company decided to get into the cannabis industry, there was this overarching question of cannabis cultivation or cannabis manufacturing.
Eventually, the company decided to venture into manufacturing because they believed it offered more margin and more opportunities than flower would. While he shares that the decision didn’t reap benefits at first, as flower prices have dropped, manufacturing has proven to be a viable option.
Interested in learning more about the Benzinga Cannabis Capital Conference? Get more information here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.